An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in North America. The aim of this clinical trial is to investigate
the safety, tolerability, pharmacokinetic and signs of bioactivity of increasing single doses
of AGS-009 in patients with systemic lupus erythematosus (SLE).